Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

The purpose of the study was to evaluate the feasibility of conditioning regimen with sequential chemotherapy (FLAG-IDA), followed by Fludarabine (5 days) + Busulfan (3 days) by parallel analysis of patients with refractory acute myeloid leukemia (AML) from two transplantation centers in China and F...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling, Devillier, Raynier, Wan, Ming, Decroocq, Justine, Tian, Liang, Fürst, Sabine, Wang, Li-Ning, Vey, Norbert, Fan, Xing, Blaise, Didier, Hu, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462832/
https://www.ncbi.nlm.nih.gov/pubmed/30082853
http://dx.doi.org/10.1038/s41409-018-0283-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462832/
https://www.ncbi.nlm.nih.gov/pubmed/30082853
http://dx.doi.org/10.1038/s41409-018-0283-5

Ejemplares similares